Literature DB >> 5212554

Walker carcinosarcoma 256 in study of anticancer agents. I. Method for simultaneous assessment of therapeutic value and toxicity.

V M Rosenoer, B C Mitchley, F J Roe, T A Connors.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5212554

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  8 in total

1.  Preclinical toxicology, pharmacokinetics and formulation of N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine (trimelamol), a water-soluble cytotoxic s-triazine which does not require metabolic activation.

Authors:  C J Rutty; I R Judson; G Abel; P M Goddard; D R Newell; K R Harrap
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  Studies on the effect of methoxy-substituted glycerol ethers on tumour growth and metastasis formation.

Authors:  B Boeryd; B Hallgren; G Ställberg
Journal:  Br J Exp Pathol       Date:  1971-06

3.  DT-diaphorase: questionable role in mitomycin C resistance, but a target for novel bioreductive drugs?

Authors:  P Workman; M I Walton; G Powis; J J Schlager
Journal:  Br J Cancer       Date:  1989-11       Impact factor: 7.640

4.  Involvement of DT-diaphorase (EC 1.6.99.2) in the DNA cross-linking and sequence selectivity of the bioreductive anti-tumour agent EO9.

Authors:  S M Bailey; M D Wyatt; F Friedlos; J A Hartley; R J Knox; A D Lewis; P Workman
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  A comparison of the effects of cytotoxic agents on the Walker 256 tumour growing in the rat and at the hamster cheek pouch.

Authors:  G M Smith
Journal:  Br J Cancer       Date:  1969-03       Impact factor: 7.640

6.  Preclinical, phase I and pharmacokinetic studies with the dimethyl phenyltriazene CB10-277.

Authors:  B J Foster; D R Newell; J Carmichael; A L Harris; L A Gumbrell; M Jones; P M Goodard; A H Calvert
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640

7.  Modulation of the toxicity and antitumour activity of alkylating drugs by steroids.

Authors:  R Shepherd; K R Harrap
Journal:  Br J Cancer       Date:  1982-03       Impact factor: 7.640

8.  Criteria for the selection of second-generation platinum compounds.

Authors:  R Shepherd; H Kusnierczyk; M Jones; K R Harrap
Journal:  Br J Cancer       Date:  1980-11       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.